annual cash & cash equivalents:
$598.00M+$131.00M(+28.05%)Summary
- As of today (August 21, 2025), DRS annual cash & cash equivalents is $598.00 million, with the most recent change of +$131.00 million (+28.05%) on December 31, 2024.
- During the last 3 years, DRS annual cash & cash equivalents has risen by +$358.00 million (+149.17%).
- DRS annual cash & cash equivalents is now at all-time high.
Performance
DRS Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$278.00M-$102.00M(-26.84%)Summary
- As of today (August 21, 2025), DRS quarterly cash & cash equivalents is $278.00 million, with the most recent change of -$102.00 million (-26.84%) on June 30, 2025.
- Over the past year, DRS quarterly cash & cash equivalents has increased by +$129.00 million (+86.58%).
- DRS quarterly cash & cash equivalents is now -53.51% below its all-time high of $598.00 million, reached on December 31, 2024.
Performance
DRS quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
DRS Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +28.1% | +86.6% |
| 3 y3 years | +149.2% | +302.9% |
| 5 y5 years | +603.5% | - |
DRS Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +149.2% | -53.5% | +694.3% |
| 5 y | 5-year | at high | +880.3% | -53.5% | +826.7% |
| alltime | all time | at high | >+9999.0% | -53.5% | >+9999.0% |
DRS Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $278.00M(-26.8%) |
| Mar 2025 | - | $380.00M(-36.5%) |
| Dec 2024 | $598.00M(+28.1%) | $598.00M(+202.0%) |
| Sep 2024 | - | $198.00M(+32.9%) |
| Jun 2024 | - | $149.00M(-6.9%) |
| Mar 2024 | - | $160.00M(-65.7%) |
| Dec 2023 | $467.00M(+52.6%) | $467.00M(+893.6%) |
| Sep 2023 | - | $47.00M(+34.3%) |
| Jun 2023 | - | $35.00M(-79.9%) |
| Mar 2023 | - | $174.00M(-43.1%) |
| Dec 2022 | $306.00M(+27.5%) | $306.00M(+385.7%) |
| Sep 2022 | - | $63.00M(-8.7%) |
| Jun 2022 | - | $69.00M(-38.9%) |
| Mar 2022 | - | $113.00M(-52.9%) |
| Dec 2021 | $240.00M(+293.4%) | $240.00M(+207.7%) |
| Sep 2021 | - | $78.00M(-14.3%) |
| Jun 2021 | - | $91.00M(+203.3%) |
| Mar 2021 | - | $30.00M(-50.8%) |
| Dec 2020 | $61.00M(-28.2%) | $61.00M(-28.2%) |
| Dec 2019 | $85.00M(-1.5%) | - |
| Dec 2019 | - | $85.00M(-27.7%) |
| Sep 2008 | - | $117.56M(+96.4%) |
| Jun 2008 | - | $59.86M(-30.6%) |
| Mar 2008 | $86.25M(-10.0%) | $86.25M(+79.0%) |
| Dec 2007 | - | $48.19M(-7.8%) |
| Sep 2007 | - | $52.27M(+53.2%) |
| Jun 2007 | - | $34.11M(-64.4%) |
| Mar 2007 | $95.83M(+7311.7%) | $95.83M(+93.4%) |
| Dec 2006 | - | $49.55M(+3732.3%) |
| Mar 2006 | $1.29M(-99.6%) | $1.29M(-99.5%) |
| Dec 2005 | - | $259.67M(+0.9%) |
| Sep 2005 | - | $257.25M(+15.0%) |
| Jun 2005 | - | $223.65M(-27.1%) |
| Mar 2005 | $306.85M(+440.3%) | $306.85M(+18.9%) |
| Dec 2004 | - | $258.17M(+259.0%) |
| Sep 2004 | - | $71.91M(+12.0%) |
| Jun 2004 | - | $64.22M(+13.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2004 | $56.79M(-40.8%) | $56.79M(+91.3%) |
| Dec 2003 | - | $29.69M(-71.1%) |
| Sep 2003 | - | $102.65M(+13.5%) |
| Jun 2003 | - | $90.43M(-5.7%) |
| Mar 2003 | $95.94M(-18.5%) | $95.94M(-35.1%) |
| Dec 2002 | - | $147.78M(+267.5%) |
| Sep 2002 | - | $40.21M(-64.9%) |
| Jun 2002 | - | $114.52M(-2.8%) |
| Mar 2002 | $117.78M(+4968.1%) | $117.78M(+13.1%) |
| Dec 2001 | - | $104.11M(+2401.5%) |
| Sep 2001 | - | $4.16M(+131.5%) |
| Jun 2001 | - | $1.80M(-22.6%) |
| Mar 2001 | $2.32M(-38.5%) | $2.32M(-72.9%) |
| Dec 2000 | - | $8.57M(+0.0%) |
| Sep 2000 | - | $8.57M(+34.0%) |
| Jun 2000 | - | $6.39M(+69.2%) |
| Mar 2000 | $3.78M(-60.9%) | $3.78M(+29.4%) |
| Dec 1999 | - | $2.92M(-57.3%) |
| Sep 1999 | - | $6.83M(-14.3%) |
| Jun 1999 | - | $7.97M(-62.9%) |
| Dec 1998 | - | $21.51M(+65.1%) |
| Sep 1998 | - | $13.03M(+66.6%) |
| Jun 1998 | - | $7.82M(-19.2%) |
| Mar 1998 | $9.67M(+2.3%) | $9.67M(-43.4%) |
| Dec 1997 | - | $17.08M(+129.7%) |
| Sep 1997 | - | $7.43M(+0.7%) |
| Jun 1997 | - | $7.38M |
| Mar 1997 | $9.46M(-58.5%) | - |
| Mar 1996 | $22.79M(+103.5%) | - |
| Mar 1995 | $11.20M(-27.6%) | - |
| Mar 1994 | $15.46M(+41.0%) | - |
| Mar 1993 | $10.96M(+31.2%) | - |
| Mar 1992 | $8.36M(-39.8%) | - |
| Mar 1991 | $13.89M(-42.6%) | - |
| Mar 1986 | $24.19M(-13.2%) | - |
| Mar 1985 | $27.89M(-35.0%) | - |
| Mar 1984 | $42.90M | - |
FAQ
- What is Leonardo DRS, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Leonardo DRS, Inc.?
- What is Leonardo DRS, Inc. annual cash & cash equivalents year-on-year change?
- What is Leonardo DRS, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Leonardo DRS, Inc.?
- What is Leonardo DRS, Inc. quarterly cash & cash equivalents year-on-year change?
What is Leonardo DRS, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of DRS is $598.00M
What is the all time high annual cash & cash equivalents for Leonardo DRS, Inc.?
Leonardo DRS, Inc. all-time high annual cash & cash equivalents is $598.00M
What is Leonardo DRS, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, DRS annual cash & cash equivalents has changed by +$131.00M (+28.05%)
What is Leonardo DRS, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of DRS is $278.00M
What is the all time high quarterly cash & cash equivalents for Leonardo DRS, Inc.?
Leonardo DRS, Inc. all-time high quarterly cash & cash equivalents is $598.00M
What is Leonardo DRS, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, DRS quarterly cash & cash equivalents has changed by +$129.00M (+86.58%)